Chronic knee pain forces millions of patients into a difficult decision: accept the rapid but temporary relief of cortisone injections, or invest in the slower but more durable healing potential of platelet-rich plasma (PRP) therapy. The choice carries significant consequences. Cortisone delivers peak pain reduction within six weeks but fades to near-baseline by one year, often accelerating cartilage degradation with repeated use. PRP injections build gradually through a biological healing cascade, achieving statistically superior outcomes at 52 weeks (VAS -28 vs cortisone -4, p<0.05) while potentially protecting joint integrity. Meta-analysis of 356 studies covering 24,000+ patients reveals a clear clinical preference shift toward PRP for chronic conditions since 2020.
This comprehensive injection comparison examines the mechanisms, timelines, success rates, costs, and long-term joint health implications of both treatments, providing the evidence-based framework you need to make an informed decision for your specific condition.
Key Takeaways
- Cortisone delivers rapid relief (peak at 6 weeks) but wears off by 15 weeks; PRP builds gradually and sustains 6-12+ months
- PRP achieves superior one-year outcomes (VAS -28 vs -4, p<0.05) and may stimulate cartilage repair
- Cortisone is best for acute severe flares; PRP ideal for mild-moderate osteoarthritis and chronic tendinopathy (60-70% success rate)
- Treatment frequency: PRP requires 1-3 injections yearly vs cortisone 3-4 injections with cartilage damage risk
- Cost and insurance: cortisone is lower per-injection but requires more frequent re-treatment; PRP is higher upfront, but fewer treatments are needed
Cortisone delivers rapid pain relief that fades within 15 weeks. PRP builds gradually over three to six months and sustains relief for a year or longer. The difference lies in mechanism: cortisone suppresses inflammation temporarily, while PRP promotes actual tissue healing through concentrated growth factors. For mild to moderate knee osteoarthritis, PRP delivers superior long-term outcomes. For acute severe flares requiring immediate relief, cortisone remains the faster option, but repeated use may accelerate cartilage breakdown.
What Are PRP Injections And How Do They Work For Knee Pain Relief?
PRP injections concentrate your platelets to five to seven times normal levels and deliver them directly into the injured joint. The concentrated platelets release growth factors that reduce inflammation, stimulate cartilage repair, and promote tissue healing at the cellular level. The procedure takes 45 to 60 minutes: blood is drawn, spun through two centrifuge cycles to separate platelets, and then injected into the knee under ultrasound guidance.
Clinical data from 356 studies covering 24,000+ patients show PRP achieves a 60-70% success rate for knee osteoarthritis. Relief builds gradually, with the first noticeable improvement appearing around week six, with peak benefit at three to six months. Duration extends to 30+ weeks and often beyond a year. The primary drawback is cost ($500-$2,500 per injection) and a three to five-day inflammatory response following the procedure. Patients must avoid NSAIDs for two to four weeks to allow the healing cascade to proceed.
What Are Cortisone Injections And How Do They Work For Knee Pain Relief?
Cortisone injections are potent anti-inflammatory agents that rapidly reduce swelling and pain in the knee joint. They work by suppressing the inflammatory response, delivering fast symptom relief without addressing the underlying cartilage degeneration. The injection is quick, widely available, and typically covered by insurance.
At six weeks post-injection, cortisone outperforms PRP significantly (VAS pain reduction of -24.3 vs -7.4, p=0.033). However, the effect peaks early and declines rapidly. By 15 weeks, cortisone’s advantage disappears. At one year, cortisone-treated patients show minimal improvement from baseline (-4 points), while PRP-treated patients maintain substantial relief (-28 points, p<0.05). Repeated cortisone use may reduce collagen synthesis and accelerate cartilage breakdown, making it best suited for acute flares rather than long-term pain management.
How Do PRP And Cortisone Injections Compare In Treating Knee Pain?
Cortisone wins on speed; PRP wins on durability. Cortisone peaks at six weeks with a -24.3 point VAS reduction (p=0.033 faster than PRP), but the effect vanishes by 15 weeks. PRP requires patience, first improvement appears around week six, with peak relief at three to six months, but sustains through one year and beyond.
Speed of Pain Relief
| Treatment | Speed of Relief | Peak Effect | Evidence |
| Cortisone | Rapid | 6 weeks (VAS -24.3) | p=0.033 faster than PRP at 6 weeks |
| PRP | Gradual | First improvement week 6; peak 3-6 months | Biological healing cascade |
Duration of Pain Relief (VAS Scores 0-100)
| Time Point | PRP VAS Score | Cortisone VAS Score | Significance |
| Baseline | 60 | 60 | , |
| 6 Weeks | 52.6 (−7.4) | 35.7 (−24.3) | Cortisone superior* |
| 15 Weeks | 42.0 (−18) | 44.0 (−16) | Cortisone waning |
| 52 Weeks | 32.0 (−28) | 56.0 (−4) | PRP superior** |
*p=0.033; **p<0.05
Effectiveness Comparison
| Treatment | Success Rate | Injections Needed | Duration | Best For |
| PRP | 60-70% knee OA; 70-100% tendonitis | 1-3 per course | 6-12+ months | Mild-moderate OA, chronic tendinopathy |
| Cortisone | High initial, declining | Every 3-4 months | 6-15 weeks | Acute severe flares |
The long-term joint health profile strongly favors PRP. Meta-analysis of 356 studies shows PRP may stimulate cartilage repair and enhance hyaluronic acid production, while cortisone carries a documented risk of reduced collagen synthesis and potential cartilage degradation with repeated use. For patients seeking sustained relief and joint preservation, PRP is the evidence-backed choice. For rapid symptom control during acute flares, cortisone remains clinically appropriate, but should not be the default long-term strategy.
What Factors Should Influence The Choice Between PRP And Cortisone Injections?
The decision hinges on three variables: severity of the flare, patient age and activity goals, and whether the condition is acute or chronic. Cortisone is the correct choice when rapid symptom control is medically necessary, for severe acute flares that limit mobility or function. PRP is the correct choice for mild to moderate osteoarthritis in patients seeking long-term joint preservation and sustained knee pain relief.
Severity-Based Factors
Choose Cortisone if:
- Acute severe flare requiring rapid relief (peak at 6 weeks)
- Need immediate symptom control for mobility restoration
Choose PRP if:
- Mild-moderate knee OA (Kellgren-Lawrence Grade II-III)
- Seeking sustained relief (30+ weeks, p<0.05 at 1 year)
- Want to avoid cartilage damage risk from repeated steroid exposure
Age Considerations
PRP is effective across ages 40-75+ and is particularly suited for active individuals prioritizing long-term joint health. Younger patients concerned about cartilage preservation should strongly favor PRP; the growth factor delivery mechanism supports tissue integrity rather than compromising it. Cortisone remains appropriate at any age when rapid relief is the clinical priority, and may suit elderly patients with severe acute flares who prioritize immediate symptom control over long-term structural considerations.
PRP Benefits for Chronic Pain
Clinical success rates by condition: knee OA (60-70% success), patellar tendinopathy (86% return to sport), lateral epicondylitis (70-100% success), and partial rotator cuff tears. The Boffa 2025 meta-analysis of 356 studies covering 24,000+ patients documents a clear clinical preference shift toward PRP since 2020, with one-year superiority maintaining statistical significance (p<0.05). For chronic tendinopathies and mild to moderate joint degeneration, PRP is now the evidence-backed first-line regenerative option.
What Are The Advantages And Disadvantages Of PRP vs. Cortisone Injections?
Both treatments deliver measurable pain relief, but through fundamentally different mechanisms with distinct risk-benefit profiles. PRP invests in tissue healing and long-term joint preservation. Cortisone trades that investment for immediate symptom suppression.
PRP Advantages
- Long-term relief: -28 VAS improvement at 1 year (p<0.05 vs cortisone)
- Tissue healing potential, not just symptom masking
- Superior safety profile with potential cartilage protection
PRP Disadvantages
- Slower onset (week 6 first improvement vs cortisone peak)
- 3-5 days post-procedure inflammation and soreness
- Higher cost ($500-$2,500 per injection), often not insurance-covered
- Must avoid NSAIDs for 2-4 weeks to preserve platelet function
Cortisone Advantages
- Rapid relief: -24.3 VAS reduction at 6 weeks (p=0.033 faster than PRP)
- Widely available and typically insurance-covered
- Simple, quick procedure with minimal preparation
Cortisone Disadvantages
- Short duration: effect wears off around 15 weeks, only -4 VAS improvement at 1 year
- Cartilage damage risk with repeated use (reduced collagen synthesis)
- Symptom masking only, no actual tissue repair
- Requires frequent re-injection every 3-4 months for sustained effect
The cost-benefit calculus is clear: cortisone buys time at the expense of tissue health; PRP buys healing at the expense of immediate relief.
How Long Do The Effects Of PRP And Cortisone Injections Last?
Cortisone peaks at six weeks and fades to near-baseline by one year. PRP builds gradually through the biological remodeling phase and sustains strong relief through 52 weeks and beyond. The divergence is statistically significant and clinically meaningful for patients seeking long-lasting knee pain solutions.
Duration Timeline
| Time Point | PRP Relief | Cortisone Relief | Finding |
| 6 Weeks | Moderate (−7.4) | Strong (−24.3)* | Cortisone faster |
| 15 Weeks | Good (−18) | Declining (−16) | Cortisone peaks, wanes |
| 52 Weeks | Strong (−28)** | Minimal (−4) | PRP sustained |
*p=0.033; **p<0.05
Long-Term Sustainability
PRP: Relief sustains from 15 weeks through 52+ weeks as the tissue remodeling phase completes. Low recurrence rate. Patients typically report 6-12+ months of functional improvement before considering repeat injection. The biological healing cascade, growth factor delivery, collagen deposition, tissue maturation, produces durable structural changes rather than temporary symptom suppression.
Cortisone: Effect wears off around 15 weeks. Pain scores return to near-baseline by one year. High recurrence rate necessitates re-injection every 3-4 months to maintain symptom control. This creates a treatment treadmill: repeated injections deliver diminishing returns while accumulating cartilage damage risk. For chronic conditions, cortisone is a holding pattern, not a solution.
How Often Can You Get PRP or Cortisone Injections For Knee Pain?
PRP requires fewer injections with longer intervals between treatments. Cortisone demands frequent re-injection to maintain symptom control, creating a cumulative cartilage damage risk. The frequency difference reflects the fundamental mechanism divide: PRP promotes healing that lasts; cortisone suppresses symptoms that return.
PRP Frequency
- 1-3 injections per course, spaced 4-6 weeks apart
- Two injections are superior to one for tendinopathy (VAS 1.07 vs 3.7; VISA-P 93.2 vs 65.7)
- Repeat the course after 6-12 months if needed
Cortisone Frequency
- Every 3-4 months as effect wears off around 15 weeks
- Limit to 3-4 injections per year per joint due to cartilage damage risk
- Minimum 6-8 week intervals between injections to reduce chondrotoxic exposure
Frequency Comparison
| Treatment | Annual Frequency | Intervals | Overuse Risk |
| PRP | 1-3 per course, repeat yearly | 4-6 weeks | Minimal with proper spacing |
| Cortisone | 3-4 per year | 6-8 weeks minimum | Chondrotoxic effects, cartilage degradation |
The treatment burden tells the story: PRP patients receive 1-3 injections and return to activity for 6-12+ months. Cortisone patients cycle back every quarter, accumulating exposure with each round.
Is One Treatment Better For Long-Term Knee Pain Relief Than The Other?
For sustained relief and recurrence prevention, PRP delivers statistically superior outcomes at one year. Cortisone returns patients to near-baseline pain levels by 52 weeks, necessitating continuous re-treatment. The clinical evidence is unambiguous: PRP addresses root cause pathology through tissue healing; cortisone masks symptoms temporarily.
Long-Term Relief
| Treatment | Recurrence Prevention | 1-Year Outcome | Satisfaction |
| PRP | Low recurrence; 6-12+ month relief | VAS -28 (p<0.05 superior) | 60-70% knee OA success |
| Cortisone | High recurrence; ~15 week effect | VAS -4 (near baseline) | Declining; requires re-injection |
Recurrence Prevention
PRP maintains statistically superior outcomes at one year (p<0.05) by addressing the root cause through tissue healing and growth factor delivery. The biological cascade reduces recurrence by actually repairing damaged structures. Cortisone returns patients to near-baseline by one year, with inevitable recurrence driving the need for repeated treatments and escalating cumulative cartilage exposure.
Suitable for Chronic Conditions
PRP is ideal for chronic degenerative and inflammatory conditions: mild-moderate knee OA (60-70% success, 6-12+ months duration), chronic patellar tendinopathy (86% return to sport), and lateral epicondylitis (70-100% success rates). Cortisone is best reserved for acute severe flares, providing short-term symptom control while the patient explores definitive long-term solutions such as PRP, physical therapy, or stem cell therapy.
What Is The Cost Comparison Between PRP And Cortisone Injections?
PRP costs more upfront but requires fewer treatments annually. Cortisone costs less per injection but demands frequent re-treatment, with cumulative costs and potential long-term joint damage offsetting the initial savings. The true cost equation includes treatment frequency, insurance coverage, and downstream consequences.
Cost Comparison
| Treatment | Per Injection | Insurance | 1-Year Total |
| PRP | $500-$2,500 | Often not covered | $500-$7,500 (1-3 injections) |
| Cortisone | Lower (varies) | Usually covered | Variable; 3-4 injections needed |
Cortisone Cost Breakdown
Lower per-injection cost, typically $10-$50 copay with insurance coverage. However, cumulative cost increases with 3-4 annual injections required for sustained symptom management. Potential additional costs emerge from long-term cartilage damage, accelerated disease progression, and eventual surgical intervention.
Cost-Effectiveness Considerations
PRP carries a higher upfront investment ($500-$2,500 per injection) but requires fewer treatments due to a 6-12+ month relief duration. The tissue healing mechanism may slow disease progression, potentially delaying or avoiding joint replacement. Cortisone offers lower per-injection cost and immediate insurance coverage, but short-term savings are offset by treatment frequency (every 3-4 months), cumulative exposure, and potential acceleration of the underlying degenerative process requiring more aggressive intervention.
Which Treatment Is Right For Your Knee Pain?
The clinical evidence establishes clear use cases for each treatment. PRP delivers superior long-term outcomes for chronic conditions, sustained relief at one year (VAS -28 vs cortisone -4, p<0.05), tissue healing potential, and 60-70% success rates for knee osteoarthritis with 6-12+ month duration. Cortisone remains the appropriate choice for acute severe flares requiring rapid symptom control, offering significantly faster relief at six weeks (p=0.033) and immediate insurance coverage.
Best Value Treatment
For long-term relief: PRP is superior, sustained 52+ weeks (p<0.05), VAS -28 vs cortisone -4 at one year, may stimulate cartilage repair, and requires fewer treatments (1-3 injections annually vs 3-4+ for cortisone).
For short-term relief: Cortisone is effective for acute needs, faster relief at 6 weeks (p=0.033), lower upfront cost, and insurance coverage for immediate symptom management.
Final Recommendations
Choose PRP therapy if you have mild-moderate knee OA, seek 6-12+ month sustained relief, want to avoid or delay surgery, are concerned about long-term cartilage health, or have chronic tendinopathy (70-100% success rates documented).
Choose Cortisone if you have an acute severe flare needing rapid relief, insurance coverage is a priority, you need short-term management before definitive treatment, or you require immediate symptom control for mobility restoration.
Consult a specialist when pain persists beyond 6-8 weeks, you’re considering regenerative options, you’ve received more than 3-4 cortisone injections per year, previous treatments have failed, or you’re discussing combination therapies or alternative approaches.
Treatment decisions should be guided by pain severity, chronicity, age, activity level, budget, joint health goals, and individual response to previous treatments. The Regenerative Institute of Newport Beach specializes in evidence-based regenerative medicine protocols for chronic joint pain. Schedule a consultation to determine which treatment is right for your specific condition.

